Daily SPAC Update – September 30, 2025

by | Sep 30, 2025

Gigcapital7 Deal with Hadron Energy. Starry Sea Binding LOI. DMY Squared Goes OTC. GSR III Gets Bigger PIPE. Healthcare AI Postpones Vote and Asks for Longer.

Boardroom Alpha SPAC Resources
– Full SPAC Listing
– SPAC SEC Filings
– Boardroom Alpha IPO & SPAC Intelligence Platform (7-Day Trial)

Daily SPAC Update

SPAC NEWS
SSEAU – STARRY SEA ACQUISITION CORP * Binding LOI
GIG – GIGCAPITAL7 CORP * Merger Agreement
DMYY – DMY SQUARED TECHNOLOGY GROUP INC * OTC Listing
GSRT – GSR III ACQUISITION CORP * PIPE Update
TBMC – TRAILBLAZER MERGER CORP I * Vote Adjourned
HAIA – HEALTHCARE AI ACQUISITION CORP * Vote Postponed

SEPARATE WARRANTS/RIGHTS
Oct 02: HIGHVIEW MERGER CORP (HVMC)

SPAC DEALS ANNOUNCED
Sep 29 | GIG – Gigcapital7 Corp + Hadron Energy

ABOUT Hadron Energy
Hadron is a pioneer in MMR technology. Designed to deliver 10 MW of power, Hadron’s MMR will be smaller, more cost-effective, and faster to deploy than other proposed MMR power solutions. The revolutionary design of Hadron’s MMR allows its reactor core and containment shell to be transportable in a shipping container, providing a versatile deployment model for end users. Whether powering an artificial intelligence data center, remote community, or an industrial hub, Hadron’s MMR is expected to provide a reliable, safe and scalable nuclear energy solution.

NEW SPAC IPOs
Sep 26: FCRS – Futurecrest Acquisition Corp. $250M IPO (+underwriter overallotment: $37.5M)
Sep 26: AEXA – American Exceptionalism Acquisition Corp. A $300M IPO
Sep 25: EMIS – Emmis Acquisition Corp. $100M IPO (+underwriter overallotment: $15M)
Sep 25: DMII – Drugs Made In America Acquisition II Corp. $500M IPO

SPAC Movers

YESTERDAY’S TOP SPAC GAINERS
6.89% ~ $ 20.95 | CEP – CANTOR EQUITY PARTNERS INC (Announced)
2.48% ~ $ 10.35 | IROH – IRON HORSE ACQUISITIONS CORP (Announced)
1.60% ~ $ 10.78 | AEXA – AMERICAN EXCEPTIONALISM ACQUISITION CORP A (Pre-Deal)
1.06% ~ $ 10.52 | GIG – GIGCAPITAL7 CORP (Announced)
.85% ~ $ 10.55 | POLE – ANDRETTI ACQUISITION CORP II (Pre-Deal)

YESTERDAY’S TOP SPAC LOSERS
-6.67% ~ $ 12.60 | ATMV – ALPHAVEST ACQUISITION CORP (Announced)
-6.15% ~ $ 12.20 | ISRL – ISRAEL ACQUISITIONS CORP (Announced)
-5.54% ~ $ 11.77 | WLAC – WILLOW LANE ACQUISITION CORP (Announced)
-4.45% ~ $ 12.44 | DMYY – DMY SQUARED TECHNOLOGY GROUP INC (Announced)
-3.35% ~ $ 15.28 | HOND – HCM II ACQUISITION CORP (Announced)

LATEST SPAC IPO PERFORMANCE
Sep 26 | $ 10.55 | FCRS – FutureCrest Acquisition Corp.
Sep 26 | $ 10.78 | AEXA – American Exceptionalism Acquisition Corp. A
Sep 25 | $ 9.98 | DMII – Drugs Made In America Acquisition II Corp.
Sep 25 | $ 10.00 | EMIS – Emmis Acquisition Corp.
Sep 19 | $ 9.99 | LATA – Galata Acquisition Corp. II
Sep 16 | $ 10.00 | CHECU – Chenghe Acquisition III
Sep 12 | $ 10.07 | OTGA – OTG Acquisition Corp. I
Sep 10 | $ 10.27 | BLZR – Trailblazer Acquisition Corp.
Sep 09 | $ 10.03 | TLNC – Talon Capital Corp.
Sep 04 | $ 10.13 | GSRF – GSR IV Acquisition Corp.
Sep 04 | $ 10.30 | SVAC – Spring Valley Acquisition Corp. III

Recent Analysis

Weekly Boardroom & Executive Moves: May 1, 2026

This week, significant leadership changes occurred across several companies facing financial difficulties. Abbott Laboratories (ABT) and Agilon Health Inc (AGL) appointed new board members and executives amidst high activist risks and declining TSRs. Accuray Inc (ARAY) and ALT5 Sigma Corp (ALTS) also saw key executive departures and appointments as they navigate substantial TSR declines. These shifts highlight the ongoing challenges and strategic redirections needed to stabilize operations and improve shareholder value.

Daily SPAC Update – May 1, 2026

Two SPAC IPOs launched today, raising a total of $500 million. CH4 Natural Solutions Acquisition Corp (MTNE) secured $300 million, while Quantum Leap Acquisition Corp (QLEP) raised $200 million. Today, 2 SPAC IPOs raised $500M, led by CH4 Natural Solutions (MTNE) at $300M. This follows a surge of activity at the end of April.

Daily SPAC Update – April 30, 2026

Today, six SPACs debuted, raising a total of $965 million. General Catalyst Global Resilience Merger Corp (GCGR) led the pack with $350 million, followed by RRE Ventures Acquisition Corp. (RREV) at $250 million. Month-to-date, SPAC IPOs total 16, bringing in $2.65 billion, compared to 11 IPOs last month that raised $1.72 billion.

Daily SPAC Update – April 29, 2026

Collective Acquisition Corp. II (CAII) launched its $220 million IPO today, targeting high-potential sectors like technology and healthcare. In executive moves, Roger Bendelac was appointed CEO of both Drugs Made in America Acquisition Corp (DMAA) and Drugs Made in America Acquisition II Corp (DMII), with Saleem Elmasri as CFO. Meanwhile, General Purpose Acquisition Corp (GPAC) saw a significant decline of 22.9%, closing at $9.96, while Aimei Health Technology Co Ltd (AFJK) gained 2.7% to $46.12.

Daily SPAC Update – April 28, 2026

SPAC IPOs Look Stalled Again as Irenic’s $220M IPO Only Makes it Seven. Miluna Acquisition + CADV.AI Deal. Prophyte Extension Vote to Add 12 More Months.

Subscribe to Boardroom Alpha Newsletters

Subscribe to Boardroom Alpha's research to receive the latest on governance, SPACs, and people.

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.